Search Results for "Turning And Repositioning Ventilator Patients"
Original Source: Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens
The purpose of this study is to compare a 2-hour versus every 4-hour turning regimen on the incidence of grade > II pressure ulcers (PU) in patients in ICU on mechanical ventilation ≥ 24h that use alternating-pressure air mattresses (APAMs).
Matching Channels
Matching News
Researchers discover potential drug targets that might reduce ventilator-induced lung inflammation
When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immu...
Lungs respond to hospital ventilator as if it were an infection
When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immu...
Spacelabs' anesthesia device, ventilator slated for U.S. launch
Spacelabs Healthcare has secured FDA clearance to launch the Blease900 ventilator in conjunction with its BleaseFocus anesthe -More-
Drug repositioning: a new path to address unmet clinical needs
Drug repositioning, the process of finding new indications for existing drugs, presents a promising avenue for identifying better and safer treatments without the full cost or time required for de nov...
The overall attributable mortality of ventilator-associated pneumonia is 13%, with higher rates for surgical patients and patients with a mid-range severity score at admission. Attributable mortality...
Reducing Ventilator-Associated Pneumonia in the NICU
What strategies can be implemented to decrease ventilator associated pneumonia in the NICU? Infection Control and Hospital Epidemiology
(MedPage Today) -- The FDA has issued two Class I recalls involving ventilator-related products.
Spacelabs Blease900 ventilator wins FDA nod
Spacelabs Healthcare, a division of OSI Systems, has received the US Food and Drug Administration's 510(k) approval for its Blease900 ventilator.
Matching PubMed Articles
Abstract Primary cheiloplasty in adult patients with unrepaired complete bilateral cleft lip and palate is quite challenging due to severe premaxillary anterior projection. To get the best repair resu...
PURPOSE: The aim of this study was to determine whether the use of a polyurethane-cuffed endotracheal tube would result in a decrease in ventilator-associated pneumonia rate. MATERIALS AND METHODS: We...
Neuromuscular Blockers and ARDS.
To the Editor: In the study reported on by Papazian et al. (Sept. 16 issue),(1) patients with the acute respiratory distress syndrome (ARDS) treated early with cisatracurium had improved 90-day surviv...
Neuromuscular Blockers and ARDS.
To the Editor: In the study reported on by Papazian et al. (Sept. 16 issue),(1) patients with the acute respiratory distress syndrome (ARDS) treated early with cisatracurium had improved 90-day surviv...
Neuromuscular Blockers and ARDS.
To the Editor: In the study reported on by Papazian et al. (Sept. 16 issue),(1) patients with the acute respiratory distress syndrome (ARDS) treated early with cisatracurium had improved 90-day surviv...
